February 19, 2024
Matt Rourke/AP

Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests

Before statins, niacin was seen as a way to increase good cholesterol and promote heart health. A new study calls that into question.

By Annalisa Merelli


Opioid cravings were reduced by anti-obesity drug in small study

Although the dropout rate was high, the trial suggests GLP-1 obesity drugs like liraglutide may be useful in opioid addiction treatment.

By Simar Bajaj


STAT+ | In ‘major milestone,’ FDA approves first cell therapy for solid tumors

A tumor infiltrating lymphocyte therapy by Iovance helped a significant number of advanced melanoma patients.

By Angus Chen



Adobe

Opinion: The complicated connections between weight loss drugs and mental health

How a psychiatrist and an endocrinologist are working together when it comes to GLP-1 weight loss drugs like Wegovy.

By Jody Dushay and Karen S. Greenberg


STAT+ | Leading MD Anderson oncologist disputes junior scientist’s claims in lawsuit over research credit

Padmanee Sharma, one of MD Anderson's most influential researchers, provided her own account of events in a contentious case.

By Angus Chen


‘All of Us’ reports half of the genomes it has sequenced are from non-Europeans

The data release this week includes the whole genome sequences of nearly 250,000 participants — half of whom are of non-European ancestry.

By Megan Molteni


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.